VKTX
Viking Therapeutics, Inc.Company with tickers: VKTX
CIK
1607678
CUSIP
92686J106
Shares Outstanding
116,105,643
13F Activity (30d)
205 filings
204 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K | 2020-02-26 | 2019-12-31 | |
| 8-K | 2020-03-17 | — | |
| 8-K | 2020-04-30 | — | |
| 10-Q | 2020-04-30 | 2020-03-31 | |
| 8-K | 2020-05-21 | — | |
| 10-Q | 2020-07-29 | 2020-06-30 | |
| 8-K | 2020-07-29 | — | |
| 8-K | 2020-10-28 | — | |
| 10-Q | 2020-10-28 | 2020-09-30 | |
| 8-K | 2021-01-06 | 2021-01-04 | |
| 8-K | 2021-02-17 | — | |
| 10-K | 2021-02-17 | 2020-12-31 | |
| 10-Q | 2021-04-28 | 2021-03-31 | |
| 8-K | 2021-04-28 | — | |
| 8-K | 2021-05-21 | 2021-05-20 | |
| 8-K | 2021-07-28 | — | |
| 10-Q | 2021-07-28 | 2021-06-30 | |
| 10-Q | 2021-11-03 | 2021-09-30 | |
| 8-K | 2021-11-03 | — | |
| 8-K | 2022-02-09 | — | |
| 10-K | 2022-02-09 | 2021-12-31 | |
| 8-K | 2022-04-27 | — | |
| 10-Q | 2022-04-27 | 2022-03-31 | |
| 8-K | 2022-05-26 | 2022-05-24 | |
| 10-Q | 2022-07-27 | 2022-06-30 | |
| 8-K | 2022-07-27 | — | |
| 8-K | 2022-10-26 | — | |
| 10-Q | 2022-10-26 | 2022-09-30 | |
| 8-K | 2023-02-08 | — | |
| 10-K | 2023-02-10 | 2022-12-31 | |
| 8-K | 2023-03-28 | — | |
| 8-K | 2023-03-31 | 2023-03-29 | |
| 8-K | 2023-04-03 | — | |
| 8-K | 2023-04-26 | — | |
| 10-Q | 2023-04-26 | 2023-03-31 | |
| 8-K | 2023-05-11 | 2023-05-09 | |
| 8-K | 2023-06-14 | 2023-06-13 | |
| 10-Q | 2023-07-26 | 2023-06-30 | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-10-25 | — | |
| 10-Q | 2023-10-25 | 2023-09-30 | |
| 10-K | 2024-02-07 | 2023-12-31 | |
| 8-K | 2024-02-07 | — | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-03-01 | 2024-02-28 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-03-26 | — | |
| 8-K | 2024-04-24 | — | |
| 10-Q | 2024-04-25 | 2024-03-31 | |
| 8-K | 2024-05-23 | 2024-05-21 |
Showing 1–50 of 73 filings